Response-independent survival benefit in metastatic colorectal cancer: a comparative analysis of N9741 and AVF2107.
      Google Scholar   
Citation:
J Clin Oncol vol 26 (2) 183-9
Year:
2008
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
No
SDC:
Yes
Book Volume:
Parents:
395  
Children:
None
Program:
OGC
Primary Committee:
GI
Sec. Committees:
   
Pharmas:
 
Grants:
CA25224  
Corr. Author:
 
Authors:
                   
Networks:
 
Study
NCCTG-N9741
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords:
Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocols, Bevacizumab, Camptothecin, Colorectal Neoplasms, Disease Progression, Drug Administration Schedule, Female, Fluorouracil, Humans, Leucovorin, Male, Multicenter Studies as Topic, Organoplatinum Compounds, Proportional Hazards Models, Randomized Controlled Trials as Topic, Retrospective Studies, Survival Analysis